78% of patients with diabetes
surveyed are ‘very or somewhat likely’
to participate in a diabetes trial NOW.
Kickoff your access to diabetes patients
with a ridiculously short form.
Get started now
We connect you with diabetes patients.
SubjectWell has more than 470,000 patients diagnosed with type 2 diabetes currently active in our marketplace. And we have referred patients to over 200 trials requiring a diabetes diagnosis.
Voice of the diabetic patient.
In a SubjectWell survey of over 300 patients with type two diabetes:
2-6% higher interest in trial participation from patients with the secondary conditions anxiety, neuropathy, or gum disease.
89% of Black and Hispanic patients reported high interest in trial participation when compensation was included.
Uncover interesting diabetes patient trends in the complete survey results.
Risk-free patient recruitment.
We do things differently at SubjectWell.
Educate patients
on the benefits clinical trials
Follow up with
telephone-based prescreening
Deliver qualified referrals missed by
traditional, study-specific methods
Charge only for patients who
randomize with risk-free pricing model
Want to see how we work?
Give us two weeks and a look at your protocol, and we’ll complete a risk-free patient recruitment assessment using real-world data to determine our enrollment impact. Here’s a sample diabetes assessment showing the types of data we’ll compile on your unique study.